You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dacarbazine

Showing 1 - 25 of 280
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)

Suspended
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
Oct 24, 2022

Advanced Melanoma Trial in Zhengzhou (Tislelizumab Injection)

Not yet recruiting
  • Advanced Melanoma
  • Tislelizumab Injection
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 4, 2022

Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)

Recruiting
  • Classical Hodgkin Lymphoma
  • Dacarbazine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Metastatic Melanoma Trial in Louisville (Proleukin and Dacarbazine)

Active, not recruiting
  • Metastatic Melanoma
  • Proleukin and Dacarbazine
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Metastatic Melanoma Stage IV Trial in Tuebingen, Siena (L19IL2 - Ph I, L19IL2 at RD - Ph II, DTIC)

Active, not recruiting
  • Metastatic Melanoma Stage IV
  • L19IL2 - Ph I
  • +2 more
  • Tuebingen, Germany
  • +1 more
Apr 13, 2022

Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

Not yet recruiting
  • Melanoma
  • tunlametinib
  • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 15, 2023

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)

Completed
Has Results
  • Hodgkin Disease
  • Brentuximab vedotin
  • +3 more
  • Aurora, Colorado
  • +13 more
Jun 17, 2022

Solitary Fibrous Tumors Trial in Italy (Trabectedin, Adriamycin, Dacarbazine)

Recruiting
  • Solitary Fibrous Tumors
  • Prato, Firenze, Italy
  • +5 more
Oct 29, 2021

Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
Aug 5, 2022

Advanced Melanoma Trial (DCB-BO1301)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Mar 17, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Non-metastatic Soft-tissue Sarcoma, Resectable Trial in France (Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the

Recruiting
  • Non-metastatic Soft-tissue Sarcoma
  • Resectable
  • Bordeaux, France
  • +9 more
Jul 27, 2022

Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Charlottesville, Virginia
    University of Virginia
Jul 27, 2022

O6-methylguanine-DNA Methyltransferase Promoter Methylation and

Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
May 14, 2021

Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

Completed
Has Results
  • Malignant Melanoma
  • Recurrent Melanoma
  • Dacarbazine
  • +2 more
  • (no location specified)
Oct 18, 2020

HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

Active, not recruiting
  • HIV Infection
  • +3 more
  • brentuximab vedotin
  • +3 more
  • Clamart, France
  • +5 more
Aug 11, 2022

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Hodgkin Lymphoma Trial in Italy, United States (Rituximab, Involved field irradiation)

Terminated
  • Hodgkin Lymphoma
  • Houston, Texas
  • +10 more
Aug 18, 2021

Hodgkin Lymphoma, Chemo Effect Trial in Guangzhou (Tislelizumab)

Recruiting
  • Hodgkin Lymphoma
  • Chemotherapy Effect
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Apr 12, 2021

Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)

Recruiting
  • Hodgkin Lymphoma
  • Involved site radiotherapy
  • +6 more
  • Aberdeen, United Kingdom
  • +6 more
May 24, 2022

Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • +3 more
  • Phoenix, Arizona
  • +22 more
Nov 1, 2022